The presence of microbleeds in the brain should not affect the decision to prescribe anticoagulation to patients after an ischemic stroke, new data suggest. "We found that microbleeds increased the ...

As one of the most powerful independent risk factors for ischemic stroke and the most clinically relevant arrhythmia, atrial fibrillation (AF) poses a serious clinical and public health threat as the ...

Please provide your email address to receive an email when new articles are posted on . Data show early anticoagulation after acute stroke in people with atrial fibrillation is safe when indicated.

January 26, 2004 — It is clear that warfarin therapy in patients with atrial fibrillation (AF) resulting in an international normalized ratio (INR) >= 2.0 reduces the risk of stroke. However, what is ...

Many patients with atrial fibrillation are not taking oral anticoagulation because of an elevated bleeding risk, and this subset faces substantial risks of both ischemic and hemorrhagic stroke, a new ...

In patients with device-detected atrial fibrillation and a prior stroke, oral anticoagulation increases bleeding without a clear reduction in stroke. This finding was presented by Prof. Paulus ...

Please provide your email address to receive an email when new articles are posted on . Inadequate anticoagulation occurred often in patients with atrial fibrillation who had an acute ischemic stroke, ...

PARIS, France—Among hospitalized patients with atrial fibrillation, an uptick in use of oral anticoagulation—driven by growing adoption of direct oral anticoagulants (DOACs)—is associated with a ...

Using a disease model, the current economic burden of stroke in the 2.3 million US patients with atrial fibrillation was estimated, and potential savings in direct costs obtainable by optimization of ...

To the Editor: Hylek and colleagues (Sept. 11 issue) 1 report that in patients with nonvalvular atrial fibrillation who were admitted with stroke, an international normalized ratio (INR) of less than ...

Despite the use of antiplatelet agents, usually aspirin, in patients who have had an ischemic stroke, there is still a substantial rate of recurrence. Therefore, we investigated whether warfarin, ...